大动脉支架试验 (COAST) 的前性,多中心凝结试验的中间结果
Jeffery Meadows1, Matthew Minahan2, Doff B McElhinney2
1From Division of Pediatric Cardiology, Department of Pediatrics, University of California, San Francisco (J.M.); Department of Cardiology, Boston Children's Hospital, MA (M.M., K.M.); Department of Cardiothoracic Surgery, Lucile Packard Children's Hospital, Stanford University, Palo Alto, CA (D.B.M.); and Division of Pediatric Cardiology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD (R.R.). jeffery.meadows@ucsf.edu.
奇瑟姆白金支架安全有效地治疗儿童和成人的大动脉缩,显示持续的血压改善. 发生了支架骨折,但没有引起严重并发症,在某些情况下需要重新干预.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 儿童心脏病学 儿童心脏病学
背景情况:
- 大动脉支架凝结试验 (COAST) 评估了Cheatham Platinum支架的本地或复发性凝结.
- 之前的COAST报告详细介绍了急性结局;这项研究提供了2年的随访数据.
研究的目的:
- 评估Cheatham Platinum支架在儿童和成年患者的安全性和有效性,在植入后2年内对大动脉缩.
- 评估长期结果,包括血压,高血压,药物使用和与支架相关的并发症.
主要方法:
- 105名患有大动脉缩的患者进行了尝试的Cheatham Platinum支架植入.
- 随访包括对血压,药物,支架完整性,大动脉壁的评估,并在2年内需要重新干预.
主要成果:
- 104个成功的植入,没有程序性死亡或严重的不良事件.
- 持续减少上至下肢血压差异和降低高血压率.
- 11名患者在2年内发生了支架骨折,有进展,但没有损失支架完整性或再阻塞.
结论:
- 奇瑟姆白金支架是安全的,并提供长期缓解大动脉阻塞.
- 虽然发生了支架骨折和进展,但它们并没有导致重大临床问题.
- 重新干预是常见的,解决早期/晚期大动脉壁损伤和需要重新扩展较小的支架.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Aortic Regurgitation III: Medical Management
Coronary Artery Disease V: Interprofessional Care

